TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer

T-cell receptor alternate reading frame protein (TARP) is a 58-residue protein over-expressed in prostate and breast cancer. We investigated TARP peptide vaccination's impact on the rise in PSA (expressed as Slope Log(PSA) or PSA Doubling Time (PSADT)), validated tumor growth measures, and tumo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncoimmunology
Egile Nagusiak: Wood, Lauren V., Fojo, Antonio, Roberson, Brenda D., Hughes, Meghan S. B., Dahut, William, Gulley, James L., Madan, Ravi A., Arlen, Philip M., Sabatino, Marianna, Stroncek, David F., Castiello, Luciano, Trepel, Jane B., Lee, Min-Jung, Parnes, Howard L., Steinberg, Seth M., Terabe, Masaki, Wilkerson, Julia, Pastan, Ira, Berzofsky, Jay A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Taylor & Francis 2016
Gaiak:
MIATA Compliant Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5007958/
https://ncbi.nlm.nih.gov/pubmed/27622067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1197459
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak